FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010763985> ?p ?o ?g. }

• W3010763985 abstract "Abstract Background The oncogene MYCN is critical for tumorigenesis of several types of cancers including neuroblastoma. We previously reported that miR-506-3p repressed MYCN expression in neuroblastoma cells. However, the mechanism underlying such regulation was undetermined since there is no miR-506-3p target site in MYCN 3’UTR. Methods By a systematic investigation combining microarray, informatics and luciferase reporter assay, we identified that the transcriptional factor pleiomorphic adenoma gene-like 2 (PLAGL2) is a direct target of miR-506-3p that mediates its regulation on MYCN expression. Using CHIP-PCR and luciferase reporter assay, we validated the transcriptional regulation of MYCN by PLAGL2 and we further demonstrated the transcriptional regulation of PLAGL2 by MYCN. We examined the function of PLAGL2 in regulating neuroblastoma cell fate by cell viability assay, colony formation and Western blotting of differentiation markers. We examined the effect of retinoic acid, the differentiation agent used in neuroblastoma therapy, on miR-506-3p, PLAGL2 and MYCN expressions by quantitative PCR and Western blots. We investigated the clinical relevance of PLAGL2 expression by examining the correlation of tumor PLAGL2 mRNA levels with MYCN mRNA expression and patient survival using public neuroblastoma patient datasets. Results We found that miR-506-3p directly down-regulated PLAGL2 expression, and we validated a PLAGL2 binding site in the MYCN promoter region responsible for promoting MYCN transcription, thereby establishing a mechanism through which miR-506-3p regulates MYCN expression. Conversely, we discovered that MYCN regulated PLAGL2 transcription through five N-Myc-binding E-boxes in the PLAGL2 promoter region. We further confirmed the reciprocal regulation between endogenous PLAGL2 and MYCN in multiple neuroblastoma cell lines. Moreover, we found that PLAGL2 knockdown induced neuroblastoma cell differentiation and reduced cell proliferation, and combined knockdown of PLAGL2 and MYCN showed a synergistic effect. More strikingly, we found that high tumor PLAGL2 mRNA levels were significantly correlated with high MYCN mRNA levels and poor patient survival in neuroblastoma patients. Furthermore, we found that retinoic acid increased expression of miR-506-3p and repressed expression of MYCN and PLAGL2. Conclusions Our findings altogether suggest that the interplay network formed by PLAGL2, MYCN and miR-506-3p is an important mechanism in regulating neuroblastoma cell fate, determining neuroblastoma prognosis, and mediating the therapeutic function of retinoic acid." @default.
• W3010763985 created "2020-03-23" @default.
• W3010763985 creator A5015199045 @default.
• W3010763985 creator A5024985310 @default.
• W3010763985 creator A5027783946 @default.
• W3010763985 creator A5040207267 @default.
• W3010763985 creator A5051694835 @default.
• W3010763985 creator A5066467801 @default.
• W3010763985 creator A5083568645 @default.
• W3010763985 date "2020-02-22" @default.
• W3010763985 modified "2023-10-14" @default.
• W3010763985 title "The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression" @default.
• W3010763985 cites W1493198798 @default.
• W3010763985 cites W1586091975 @default.
• W3010763985 cites W1873259379 @default.
• W3010763985 cites W1889505014 @default.
• W3010763985 cites W1923242806 @default.
• W3010763985 cites W1948356811 @default.
• W3010763985 cites W1964760527 @default.
• W3010763985 cites W1965254413 @default.
• W3010763985 cites W1965672676 @default.
• W3010763985 cites W1970404483 @default.
• W3010763985 cites W1979056528 @default.
• W3010763985 cites W1981605356 @default.
• W3010763985 cites W1986082682 @default.
• W3010763985 cites W1986885172 @default.
• W3010763985 cites W1987160935 @default.
• W3010763985 cites W1993347240 @default.
• W3010763985 cites W1998349351 @default.
• W3010763985 cites W2019188434 @default.
• W3010763985 cites W2020555116 @default.
• W3010763985 cites W2024280594 @default.
• W3010763985 cites W2026959715 @default.
• W3010763985 cites W2029126296 @default.
• W3010763985 cites W2035097653 @default.
• W3010763985 cites W2042534820 @default.
• W3010763985 cites W2044033792 @default.
• W3010763985 cites W2057364464 @default.
• W3010763985 cites W2058797935 @default.
• W3010763985 cites W2060249724 @default.
• W3010763985 cites W2060737851 @default.
• W3010763985 cites W2062175667 @default.
• W3010763985 cites W2063960043 @default.
• W3010763985 cites W2070547356 @default.
• W3010763985 cites W2073193791 @default.
• W3010763985 cites W2074429464 @default.
• W3010763985 cites W2077058303 @default.
• W3010763985 cites W2078610083 @default.
• W3010763985 cites W2083381199 @default.
• W3010763985 cites W2085324333 @default.
• W3010763985 cites W2096797981 @default.
• W3010763985 cites W2102970911 @default.
• W3010763985 cites W2106452303 @default.
• W3010763985 cites W2112738731 @default.
• W3010763985 cites W2117145998 @default.
• W3010763985 cites W2117339909 @default.
• W3010763985 cites W2144822980 @default.
• W3010763985 cites W2147800896 @default.
• W3010763985 cites W2155044281 @default.
• W3010763985 cites W2158115867 @default.
• W3010763985 cites W2205128017 @default.
• W3010763985 cites W2327522594 @default.
• W3010763985 cites W2330923897 @default.
• W3010763985 cites W2531260053 @default.
• W3010763985 cites W2733135103 @default.
• W3010763985 cites W2782170329 @default.
• W3010763985 cites W2792966374 @default.
• W3010763985 cites W2794385660 @default.
• W3010763985 cites W2795419764 @default.
• W3010763985 cites W2795690442 @default.
• W3010763985 cites W2797653167 @default.
• W3010763985 cites W2883500270 @default.
• W3010763985 cites W2897722799 @default.
• W3010763985 cites W2905329311 @default.
• W3010763985 cites W2919505481 @default.
• W3010763985 cites W4239261246 @default.
• W3010763985 cites W92934419 @default.
• W3010763985 cites W2066344363 @default.
• W3010763985 doi "https://doi.org/10.1186/s13046-020-1531-2" @default.
• W3010763985 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7036248" @default.
• W3010763985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32087738" @default.
• W3010763985 hasPublicationYear "2020" @default.
• W3010763985 type Work @default.
• W3010763985 sameAs 3010763985 @default.
• W3010763985 citedByCount "16" @default.
• W3010763985 countsByYear W30107639852020 @default.
• W3010763985 countsByYear W30107639852021 @default.
• W3010763985 countsByYear W30107639852022 @default.
• W3010763985 countsByYear W30107639852023 @default.
• W3010763985 crossrefType "journal-article" @default.
• W3010763985 hasAuthorship W3010763985A5015199045 @default.
• W3010763985 hasAuthorship W3010763985A5024985310 @default.
• W3010763985 hasAuthorship W3010763985A5027783946 @default.
• W3010763985 hasAuthorship W3010763985A5040207267 @default.
• W3010763985 hasAuthorship W3010763985A5051694835 @default.
• W3010763985 hasAuthorship W3010763985A5066467801 @default.
• W3010763985 hasAuthorship W3010763985A5083568645 @default.
• W3010763985 hasBestOaLocation W30107639851 @default.
• W3010763985 hasConcept C104317684 @default.
• W3010763985 hasConcept C111335760 @default.

• next